Nov 21, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 21, 2014 - Global electrophysiology devices market is expected to reach USD 6.19 billion by 2020, according to a new study by Grand View Research, Inc

Nov 21, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 21, 2014 - Global medical device outsourcing market is expected to reach USD 50.37 billion by 2020, according to a new study by Grand View Research, Inc

Nov 21, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 21, 2014 - Global radiofrequency ablation devices market is expected to reach USD 8.85 billion by 2020, according to a new study by Grand View Research, Inc

Nov 21, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 21, 2014 - WinterGreen Research announces that it has published a new study Energy Harvesting Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019

Nov 21, 2014, 00:00 AM by Michael Croft

NCBI | NCBI's Eukaryotic Genome Annotation Pipeline has completed the annotation of more than 100 organisms so far in 2014. 81 of the annotations thus far have been first annotations.

Nov 21, 2014, 00:00 AM by Michael Croft

NEW YORK, NY, UNITED STATES - Nov 21, 2014 - According to a new market report published by Persistence Market Research "Global Market Study on Bioinformatics - Asia to Witness Fastest Growth by 2020,"

Nov 21, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 21, 2014 - Global microscopes market is expected to reach USD 9.54 billion by 2020, according to a new study by Grand View Research, Inc

Nov 20, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Nov 20, 2014 - Synopsis
Disease-related, demographic, and desire-led drivers are making health of growing importance to food marketers

Nov 20, 2014, 00:00 AM by Michael Croft

VAUGHAN, ON - Nov 20, 2014 - The aqueous solubility of fragments is often a limiting factor for biophysical techniques used in fragment-based drug design (FBDD) such as nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), X-ray diffraction (XRD), high concentration analysis (HCA) etc

Nov 19, 2014, 11:20 AM by Michael Croft

Bio-IT World News Brief | BioMérieux, a French-headquartered biotech specializing in diagnostics and microbe detection, has announced a partnership with sequencing giant Illumina to create next generation sequencing tests for tracking pathogens during local outbreaks.

Nov 19, 2014, 08:20 AM by Michael Croft

Bio-IT World | At last week's Personal Genomes meeting at Cold Spring Harbor Laboratory, a debate over the evidence bar for using genetic tests threw into relief some of the stubborn questions around personal genomes' clinical utility.

Nov 19, 2014, 00:00 AM by Michael Croft

AUSTIN, TX - Nov 19, 2014 - Lab7 Systems, Inc., the developer of the Enterprise Sequencing Platform for the management of next-generation genome sequencing (NGS) data and workflows, has announced BioBuilds 2014

Nov 19, 2014, 00:00 AM by Michael Croft

PRINCETON, NJ - Nov 19, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has released version 14 of its Simcyp™ Population-based Simulator, which enables biopharmaceutical researchers to predict drug-drug interactions and pharmacokinetic-pharmacodynamic (PK-PD) outcomes in virtual human and animal populations

Nov 19, 2014, 00:00 AM by Michael Croft

Pharmalot | Shire is shifting U.S. headquarters, 500 jobs and some of its most important operations from suburban Philadelphia to the greater Boston area.

Nov 19, 2014, 00:00 AM by Michael Croft

Computerworld | The U.S. has set 2023 as the target date for producing the next great leap in supercomputing, if its plans aren't thwarted by two presidential and four Congressional elections between now and then.

Nov 18, 2014, 00:00 AM by Michael Croft

Pharmalot | Later today, the Tufts Center for the Study of Drug Development will release a report that will take yet another stab at determining the true cost of developing a medicine. In the meantime, Ed Silverman is running a poll.

Nov 18, 2014, 00:00 AM by Michael Croft

MUNICH, GERMANY - Nov 18, 2014 - Major opportunities are on the horizon for personalized medicine and clinical cancer research and treatment, according to Definiens, the global leader in Tissue Phenomics® for oncology diagnostics

Nov 17, 2014, 15:00 PM by Michael Croft

Computerworld | The latest Top500 list is out, but only one new system made it into the top ten. The Chinese Tiahne-2 has kept its number on position for the fourth time, even though it has not changed its computing power.

Nov 17, 2014, 11:00 AM by Michael Croft

Bio-IT World Roundup | The results of the IMPROVE-IT trial were announced today, a seven-year study looking at whether Merck's Vytorin and Zetia pills actually prevent heart attack. The answer: yes. At least some.

Nov 17, 2014, 00:00 AM by Michael Croft

NEW YORK, NY, UNITED STATES OF AMERICA - Nov 17, 2014 -  Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of a method development project conducted in partnership with GlaxoSmithKline plc (GSK) to evaluate the impact of unifying mobile health (mHealth) devices with cloud-based technologies in a clinical trial setting